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ABSTRACT 
Sympathomimetic and trace amines, including β-phenylethylamine (PEA) and amphetamine, 
increase blood pressure and constrict isolated blood vessels. By convention this is regarded as 
a sympathomimetic response, however, recent studies suggest trace amine-associated 
receptor (TAAR) involvement. There is also uncertainty whether these amines also release 
nitric oxide (NO) causing opposing vasodilatation. These questions were addressed in guinea-
pig isolated aorta, a species not previously examined. Guinea-pig aortic rings were set up to 
measure contractile tension. Cumulative concentration-response curves were constructed for 
the reference α-adrenoceptor agonist, phenylephrine, PEA or d-amphetamine before and in 
the presence of vehicles, the α1-adrenoceptor antagonist, prazosin (1 µM), the nitric oxide 
synthase inhibitor, Nω-nitro-L-arginine (L-NAME), or NO scavengers, curcumin and
astaxanthin. Prazosin inhibited phenylephrine contractions with low affinity consistent with 
α1L-adrenoceptors. However, PEA and amphetamine were not antagonised, indicating non-
adrenergic responses probably via TAARs. L-NAME potentiated contractions to PEA both in 
the absence and presence of prazosin, indicating that PEA releases NO to cause underlying 
opposing vasodilatation, independent of α1-adrenoceptors. L-NAME also potentiated 
amphetamine and phenylephrine. PEA was potentiated by the NO scavenger astaxanthin but 
less effectively. Curcumin, an active component of turmeric, however, inhibited PEA. Trace 
amines therefore constrict blood vessels non-adrenergically with an underlying NO-mediated 
non-adrenergic vasodilatation. This has implications in the pressor actions of these amines 
when NO is compromised. 
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3 
 
1. Introduction 
Trace amines including β-phenylethylamine (PEA) and tyramine occur in the body in trace 
amounts and are widespread in our diet (Burchett and Hicks, 2006). They cause 
vasoconstriction in isolated blood vessels including aortic rings from rats (Maling et al., 
1971; Krishnamurty and Grollman, 1972; Fehler et al., 2010) guinea-pigs (Maling et al., 
1971) and rabbits (Maling et al., 1971) and porcine coronary arteries (Herbert et al., 2008). 
This is reflected in vivo as a pressor response, oral administration of tyramine to humans 
increasing blood pressure (Peatfield et al., 1983). In animals, intravenously administered 
tyramine and PEA increase the blood pressures of rats (Day, 1967; Liles et al., 2006; 
Khwanchuea et al., 2008), cats (Burn and Rand, 1958; Day, 1967), dogs (Kohli and 
Goldberg, 1982; Woodman and Pannangpetch, 1994) and rabbits (Du et al., 1992). 
The conventionally accepted mechanism for these amines is that they are indirectly acting 
sympathomimetic amines releasing noradrenaline from sympathetic neurones onto vascular 
α1-adrenoceptors causing vasoconstriction and a rise in blood pressure (Broadley, 2010). 
However, emerging evidence suggests this mechanism may not entirely explain the 
vasoconstriction since we have shown that the vasoconstriction by PEA of rat isolated aorta 
(Fehler et al., 2010; Broadley et al., 2013) and pig coronary artery (Herbert et al., 2008) is not 
inhibited by the α1-adrenoceptor antagonist, prazosin. We proposed that the vasoconstriction 
was therefore due to an action on trace amine-associated receptors (TAARs) which were 
identified in the rat aorta (Fehler et al., 2010). 
In other isolated blood vessels such as the rat perfused mesenteric bed, tyramine and PEA, 
cause vasodilatation rather than vasoconstriction (Anwar et al., 2012) which was blocked by 
the nitric oxide synthase (NOS) inhibitor, Nω-nitro-L-arginine (L-NAME), and attributed to 
nitric oxide (NO) release (Anwar et al., 2012). Tyramine infusion to humans increased 
systolic blood pressure but increased forearm blood flow which also indicated a paradoxical 
vasodilatation (Jacob et al., 2003). This raises the question whether vessels that display a 
predominant vasoconstriction, such as the aorta, also exhibit an underlying vasodilatation 
mediated via NO. In an earlier study we found no effect of L-NAME on the vasoconstriction 
by PEA in rat aorta (Fehler et al., 2010). However, L-NAME potentiated the vasoconstriction 
by tryptamine in rat mesenteric vascular beds (Anwar et al., 2013) and the pressor response to 
tyramine in conscious rabbits (Du et al., 1992). Therefore the present study aimed to resolve 
these discrepancies using guinea-pig aorta, a species not previously employed to study non-
adrenergic vascular responses to PE. We examine the hypothesis that there is an underlying 
NO-mediated vasodilator response to PEA and amphetamine by using both the NOS inhibitor 
L-NAME and a novel approach of scavenging NO with curcumin and astaxanthin (Sumanont 
et al., 2004). This study therefore additionally examined curcumin, the active constituent of 
turmeric (Ravindran, 2007), on the vascular responses to trace amines and α-adrenoceptor 
agonists. Anti-inflammatory and anti-allergic properties of curcumin are well known (Kurup 
and Barrios, 2009) but there is little information on its cardiovascular effects. 
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2. Materials and methods
2.1. Guinea-pig isolated aortic rings 
Male Dunkin-Hartley guinea-pigs (250-350g) (Charles River, U.K.) were given one week to 
acclimatise with their new surroundings before commencement of experiments. They were 
housed in flat bottomed cages with environmental enrichment in the form of cardboard tubes 
and hay and were given food and water ad-libitum. The housing room conditions were: 
twelve hour light/dark cycles, at 50% humidity and room temperature of 20°C±2°C. Guinea-
pigs were killed by cervical dislocation and exsanguination. The guidelines for the care and 
use of laboratory animals were followed according to the Animals (Scientific Procedures) Act 
1986. The work and its reporting were undertaken according to the principles for transparent 
reporting and scientific rigour of preclinical research as set out in the Basel Declaration 
(McGrath et al., 2015). 
The thoracic aorta was removed and cut into at least four ring sections approximately 0.5 cm 
long, through which were passed fixed and mobile hangers. The fixed hanger was secured in 
a 50 ml organ bath. The bath was filled with pre-warmed (37°C) Krebs-bicarbonate buffer 
gassed with CO2/O2 (5%/95%) (BOC Gases, Guildford, UK). The Krebs bicarbonate buffer 
was made up in distilled water and had the following composition (mM): NaCl (118), 
NaHCO3 (25), glucose (11.7), MgSO4.7H2O (1.2), KH2PO4 (1.2), KCl (4.7) and CaCl2.2H2O 
(2.5). Organ baths were maintained at 37±0.5ºC by a circulator (type KD Grant Instruments, 
Cambridge, UK). A suture attached to the upper mobile hanger was connected to an isometric 
transducer (Dynamometer UF1, 57 g sensitivity range, Pioden Controls Ltd., Canterbury, 
UK) and a resting tension of 1.5 g was applied. Isometric tension was measured and 
displayed on a computer (Power Lab, Chart 5, ADInstruments, Chalgrove, Oxfordshire, UK). 
To check that functional endothelium was not removed by this set-up procedure, in a 
selection of tissues prior to commencing the protocol, acetylcholine (100 µM) was added to 
aortic rings precontracted with U46619 (1 µM). Small vasodilator responses of 0.07±0.02 g 
(n=6) were observed, which represented 7.1±3.0% of the contraction to U46616 (1.33±0.27 
g). It could therefore be concluded that a functional endothelium was present, although this 
was relatively minor compared with rat aorta where acetylcholine relaxed U46619-induced 
contractions by 72±4% (Bullock et al., 1986). 
2.2.     Experimental protocol 
After 1 hour equilibration, a cumulative concentration-response curve (CRC) for β-
phenylethylamine (PEA), amphetamine or phenylephrine was obtained by addition of half 
logarithmic increments in concentration, each successive concentration being added after the 
peak effect was reached for the preceding concentration. After the maximum effect, the tissue 
was washed and again after approximately 15 min to restore baseline. A second CRC was 
then constructed in the presence of inhibitors, their vehicles or nothing (control). Inhibitors 
and vehicles were left in contact with the tissue for 15 min before commencing the second 
CRC. At the end of each experiment, isotonic KCl (60 mM) was routinely added. It was 
decided to add the KCl without washout to avoid further decline in the baseline before adding 
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the KCl, which may have affected its response. Also, we wanted to measure the KCl 
maximum in the presence of the maximum effect of agonist. It must be admitted that the 
presence of the antagonist, however, may have influenced the KCl maximum. The second 
CRC was routinely found to be potentiated as described in the results section. However, we 
elected not to produce three CRCs and discard the first because this would have added 
another confounding factor and secondly we were interested in distinguishing this 
potentiating effect from effects of inhibitors. 
2.3.  Analysis of results 
Contractions at the plateau response to each concentration of agonist were measured from the 
baseline before the CRC. These were then expressed as a percentage of the contraction to 
KCl in each experiment, to normalize each response to the maximum contractility of each 
tissue. The mean responses (±S.E.M.) were then plotted. n values are the number of guinea-
pigs providing aortae. Maximum responses before and after inhibitors and at individual 
concentrations were compared by paired Student’s t-tests. The entire curves before and after 
inhibitors were compared by repeated-measures two-way analysis of variance (ANOVA). 
EC20 values were calculated as the molar concentration required to produce 20% of the 
maximum response to KCl. This was to ensure that values were obtained for all tissues as not 
all reached 50% of the KCl maximum contraction. These were converted to the –log EC20 
values and the mean values (±S.E.M.) calculated. They were compared by Student’s paired t-
tests. Differences were considered significant when P<0.05. CRCs obtained before and after 
prazosin or its vehicle were plotted as a percentage of the first curve maximum response so 
that dose-ratios for the shifts of CRCs could be calculated from the true EC20 values . The 
dose-ratio (DR) was calculated as the difference in the –logEC20 values in the absence and 
presence of prazosin and the –log KD was calculated from the equation: -log KD=log[A]-
log(DR-1), where A is the molar concentration of antagonist.  
2.4. Drugs used 
D-Amphetamine sulphate, astaxanthin, curcumin, Nω-nitro-L-arginine methyl ester 
hydrochloride (L-NAME), prazosin hydrochloride, (-)-phenylephrine hydrochloride, β-
phenylethylamine hydrochloride (PEA) and U46619 (9,11-Dideoxy-11α,9α-
epoxymethanoprostaglandin F2α) were obtained from Sigma-Aldrich, (Poole, Dorset, UK). 
All chemicals for the Krebs-bicarbonate buffer were of analytical grade and were obtained 
from Fisher Scientific, Leicestershire, UK. Amphetamine, PEA, L-NAME and phenylephrine 
were dissolved in distilled water. Prazosin hydrochloride was dissolved in dimethylsulfoxide 
(DMSO):distilled water (1:10) and further diluted 1 in 10 with DMSO:water (1:10). 
Curcumin and astaxanthin were dissolved in neat DMSO. The amounts of DMSO in contact 
with the tissues were 0.04µl and 4µl, respectively. 
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3. Results 
3.1. Effects of prazosin on contractions to PEA, phenylephrine and 
amphetamine 
β-Phenylethylamine (PEA) caused concentration-related constriction of the guinea-pig aorta 
with a -log EC20 of 3.98±0.21 (Fig. 1A). There was a small upwards shift of the CRC in the 
presence of DMSO (1:10) which was significant at the maximum (Fig. 1B). However, in the 
presence of the α1-adrenoceptor antagonist, prazosin (1 μM), the CRC was not affected (Fig. 
1C). The α-adrenoceptor agonist, phenylephrine, also caused dose-related contractions of the 
guinea-pig aorta, with a –log EC20 value of 5.61±0.16. These responses were enhanced on 
repeating in the control experiments in the presence of 1:10 DMSO (Fig. 2A). In the presence 
of prazosin (1 µM), the CRC was displaced to the right (Fig. 2B). The dose-ratio (DR) for the 
shift of the mean CRCs at the EC20 was 30.5 which yielded a –log KD value of 7.47±0.09 
calculated from the individual dose-ratios. Amphetamine caused concentration-related 
constriction of guinea-pig aortic rings which was not affected in the presence of the DMSO 
(1:10) vehicle (Fig. 3A). Prazosin (1 μM) potentiated the responses, significantly shifting the 
CRC upwards and to the left (Fig. 3B). The mean -logEC10 values in the presence and 
absence of prazosin were 4.0±0.3 and 3.2±0.3 respectively. 
3.2. Effects of L-NAME on contractions to PEA, amphetamine and 
phenylephrine  
In control experiments, the PEA CRC was not affected in the presence of the distilled water 
vehicle (Fig. 4A). However, in the presence of the NO synthase inhibitor, L-NAME (100 
μM), there was a significant upwards shift of the CRC (Fig. 4B). The maximum response was 
significantly increased from 59.1±3.6 to 87.5±2.8 %KCl. To assess whether L-NAME would 
still potentiate the response to PEA when α1-adrenoceptors were blocked and therefore PEA 
could not be constricting the aorta through α1-adrenoceptors, these experiments were repeated 
in the presence throughout of prazosin (1 μM). As before, L-NAME (100 μM) caused 
significant potentiation of the vasoconstriction to PEA, the CRC was elevated and the 
maximum response was significantly increased from 55.3±6.4 to 86.9±3.5 %KCl (Fig. 4C). 
L-NAME had no effect on the resting tension and in the presence of prazosin the resting 
tension was 1.45±0.13 g before adding L-NAME, 1.44±0.13 g immediately after L-NAME  
and 1.42±0.12 g at 15 min after adding L-NAME. 
In amphetamine control experiments, there was a small increase in the amphetamine CRC in 
the presence of distilled water, the maximum increasing from 36.0±3.3 to 44.7±1.1 %KCl 
(Fig. 5A). However, in the presence of L-NAME (100 μM), the CRC was substantially raised 
and the maximum contraction was significantly increased from 42.0±1.0 to 69.0±2.5 %KCl 
(Fig. 5B). 
There was a small but significant increase in the maximum response for phenylephrine in the 
control experiments in the presence of distilled water from 70.7±4.1 to 78.9±4.9 %KCl (Fig. 
6A). In the presence of L-NAME (100 μM), the maximum response was also significantly 
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raised from 75.8±3.2 to 94.0±0.8 %KCl (Fig. 6B). This increase was significantly greater 
than for the control experiments when measured as the mean differences in response between 
first and second curve, which were 8.1±2.4 %KCl for the control and 18.2±1.9 %KCl for the 
presence of L-NAME. L-NAME had no effect on the resting tension, which was 1.36±0.09 g 
before and 1.30±0.09 g at 30 min after adding L-NAME. 
3.3    Effects of curcumin and astaxanthin on contractions to phenylephrine and 
PEA  
In the presence of the NO scavenger, curcumin (100 μM), the contractions of the aorta to 
phenylephrine were unaffected. In contrast, the contractions to PEA were significantly 
reduced by this concentration of curcumin from 103.4±4.9 to 74.5±2.7 %KCl at the 
maximum response (Fig. 7B). The bath turned orange when curcumin was added. In the 
presence of phenylephrine but not PEA, this faded, suggesting some reaction with 
phenylephrine. The tissue became coated with an orange deposit in both experiments. 
Curcumin was dissolved in neat DMSO and the control experiments in the presence of an 
equivalent volume of neat DMSO showed no effect upon PEA contractions (Fig. 7C). 
Astaxanthin (100 μM), another NO scavenger, exerted a small but significant potentiation of 
the maximum contraction to PEA from 72.1±3.2 to 81.6±6.2 %KCl, although the whole CRC 
was not significantly affected (Fig. 7D). 
 
4. Discussion 
β-Phenylethylamine (PEA) and amphetamine are traditionally known as sympathomimetic 
amines (Broadley, 1996). However, they may also be categorized as agonists at trace amine-
associated receptors (TAARs) (Bunzow et al., 2001). PEA and amphetamine exerted 
vasoconstriction of guinea-pig isolated aortic rings, similar to the α-adrenoceptor agonist, 
phenylephrine. Phenylephrine was antagonised by the α1-adrenoceptor antagonist, prazosin. 
The –log KD value for prazosin of 7.47±0.09 is two orders of magnitude less potent than the 
values of 9.9 and 9.8 obtained previously in rat aorta (Hussain and Marshall, 1997; Kenny et 
al., 1995). However, it is similar to the value of 7.83 obtained by Yamamoto and Koike 
(1999) in guinea-pig thoracic aorta. Therefore the α-adrenoceptor subtype mediating 
contraction of the guinea-pig aorta is similar pharmacologically to α-adrenoceptors in human 
lower urinary tract and rabbit mesenteric artery and urethra where it has been designated as 
an α1L-adrenoceptor subtype (Flavahan and Vanhoutte, 1986). In the rat aorta, in contrast, the 
receptors belong to the α1D-subtype (Kenny et al., 1995; Hussain and Marshall, 1997). 
While prazosin shifted the concentration-response curve for phenylephrine, it did not 
antagonise PEA. This demonstrates for the first time in guinea-pig aorta that the 
vasoconstriction to PEA is not mediated via α-adrenoceptors and that it is not acting as a 
sympathomimetic amine. Thus, the vasoconstriction cannot be explained by the classical 
indirect sympathomimetic action of noradrenaline release from noradrenergic neurones onto 
α-adrenoceptors. This observation confirms our previous studies where the vasoconstriction 
8 
 
by PEA of rat isolated aorta (Fehler et al., 2010; Broadley et al., 2013) and pig coronary 
artery (Herbert et al., 2008) was not inhibited by prazosin. Narang et al. (2014) have shown 
that PEA binds to both α1- and α2-adrenoceptors in rat brain homogenates and propose that it 
is an antagonist at these receptors. Thus, the contraction to PEA is unlikely due to agonist 
activity at α2-adrenoceptors. Indeed, we have eliminated α2-adrenoceptors, since the 
contractions of rat aorta were not inhibited by yohimbine, which antagonised contractions to 
clonidine (Broadley et al., 2013).  We conclude that the response is mediated via TAARs 
which we have shown to be present in rat aorta (Fehler et al., 2010). In the case of 
amphetamine, rather than exert no effect on the contractions, prazosin potentiated the 
contractions. We did not observe this effect previously on rat aorta (Broadley et al., 2013), 
where prazosin was not used alone but in combination with cocaine, pargyline and ICI-
118,551 to block neuronal uptake, monoamine oxidase and β2-adrenoceptors, respectively. 
The reason for this potentiation is unclear. It must arise from blockade by prazosin of an 
opposing inhibitory action of amphetamine. This is unlikely to be an α1-adrenoceptor-
mediated response since this would be contractile not vasodilator. It is possible that 
amphetamine releases a vasodilator substance in the vascular wall, such as nitric oxide (NO), 
which is inhibited by prazosin. However, there is no evidence in the literature for prazosin 
having nitric oxide synthase inhibitory properties. Could it be a NO scavenger similar to 
curcumin and astaxanthin which we discuss later? The degree of potentiation is substantially 
greater than observed with astaxanthin (see later) at a concentration 100-fold greater. It is 
therefore unlikely to be a NO scavenging effect. Further work would be required to explain 
this interesting property of amphetamine.  
Having established that PEA and amphetamine constrict guinea-pig aorta by a non-adrenergic 
mechanism, we then examined whether these amines cause an opposing vasodilatation by 
using the NOS inhibitor, L-NAME. In the presence of L-NAME, both PEA and amphetamine 
were significantly potentiated. This result is at variance with our previous studies in which L-
NAME had no effect on the vasoconstriction by PEA in rat aorta (Fehler et al., 2010). 
However, the vasoconstriction of rat mesenteric bed by tryptamine was potentiated by L-
NAME (Anwar et al., 2013) and Du et al. (1992) showed that L-NAME enhanced the pressor 
response to tyramine in conscious rabbits. The previous study in rat aortae was probably not 
sufficiently robust to enable the potentiation to be detected. For example, only single dose-
response curves were constructed in each preparation either in the absence or presence of L-
NAME. The between-tissue variance was therefore too great to permit identification of the 
potentiation. Furthermore, in the previous study we were not aware that the non-adrenergic 
responses to PEA and other trace amines develop more slowly than the α-adrenoceptor-
mediated responses to phenylephrine (Broadley and Richards, 2015). It was therefore 
necessary to allow each concentration to fully contract the tissue which was usually about 20 
min. The potentiating action of L-NAME was confirmed with amphetamine. Both amines 
therefore release NO which exerts an opposing vasodilator action which, when prevented by 
nitric oxide synthesis inhibition, allows the full vasoconstrictor action to occur. 
The question arises whether this release of NO is due to α-adrenoceptor stimulation since it is 
known that α-adrenoceptor agonists release NO, probably from the endothelium. L-NAME 
9 
 
potentiated the contractions to phenylephrine of rat aortic rings with intact endothelium. 
There was also a small significant potentiation of the constrictions to phenylephrine in the 
control experiments. However, the potentiation by L-NAME was significantly greater. This 
potentiation has been attributed to inhibition by L-NAME of NO release from the 
endothelium via α1-adrenoceptors (Tabernero et al., 1996). Similarly, in rat cremester 
arterioles, L-NAME potentiates the vasoconstriction by phenylephrine through inhibition of 
the α1-adrenoceptor-mediated release of NO from the endothelium (Tuttle and Falcone, 
2001). In other blood vessels, such as the rabbit isolated pulmonary artery, NO can be 
released from the endothelium by α2-adrenoceptor stimulation (MacLean et al., 1993). Thus, 
did L-NAME potentiate PEA because PEA stimulates NO release from the endothelium via 
α1-adrenoceptors? To answer this question L-NAME was examined in the presence of 
prazosin to block α1-adrenoceptors. The vasoconstriction was still potentiated to the same 
extent, thus eliminating a role for α1-adrenoceptors in NO release by PEA. Whether TAARs 
are involved in the response is a matter for further study. The potentiation of these three 
amines by L-NAME was not due to a common inhibition of baseline NO production because 
addition of L-NAME to the tissues did not cause any increase in baseline tension.  Further 
support for this conclusion was the observation that the potentiation of contractions by L-
NAME was not by a parallel shift of the dose-response curves but by increases only towards 
the maximum. If it was due to increases in baseline, the lower doses of agonist would also be 
potentiated. 
The potentiation of phenylephrine on repeating a second CRC in control experiments is a 
phenomenon that has been observed before (Demirel and Türker, 1989; Ford and Broadley, 
1999). Although Demirel and Türker (1989) attributed this potentiation to the presence of the 
endothelium, it is generally regarded as due to an increase in the myofilament sensitivity to 
calcium induced by the α1-adrenoceptor stimulation during the first exposure (Nishimura et 
al., 1989) and is known as Ca2+ sensitization (Somlyo and Somlyo, 1993). This effect was not 
observed with PEA when distilled water was the vehicle, but there was a potentiation when 1 
in 10 DMSO was the vehicle. It is not clear why this discrepancy occurred but does suggest 
that PEA may also cause Ca2+ sensitization under certain circumstances. 
Next we examined an alternative mode of inhibiting levels of NO; by use of the NO 
scavengers curcumin and astaxanthin. This would identify whether such an approach was 
appropriate for studying the role of NO in pharmacological responses. Both curcumin, a 
component of turmeric powder, and astaxanthin, the pigment providing colour to salmon and 
shrimp, are NO scavengers with in vitro IC50 values of 20.39±4.10 and 3.42±0.50 μM, 
respectively (Sumanont et al., 2004). We used 100 μM of both substances, which was 
therefore well in excess of their IC50 values. Curcumin had no effect on phenylephrine 
contractions and therefore did not mimic NOS inhibition by L-NAME. However, curcumin 
unexpectedly caused inhibition of the contractions to PEA. One possibility is that curcumin is 
relatively unspecific and scavenges other reactive oxygen species (ROS) such as superoxide 
anion. ROS degrade NO to form peroxynitrite thus lowering its levels. Indeed, the free 
radical scavenger, edaravone, increases the levels of NO in the microcirculation rather than 
reducing it (Yamashita et al., 2013). To further illustrate the complex interactions that may 
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occur between NO and other reactive oxygen species, it has been shown that L-DOPA can 
inhibit NO-dependent vasorelaxation and therefore potentiate phenylephrine contractions of 
the aorta by generating ROS which scavenge the NO (Yanhua et al., 2009). Thus, a non-
specific scavenger such as curcumin may exert the opposite effect to what was expected. 
However, this explanation seems unlikely because the same did not occur with contractions 
to phenylephrine, which like PEA was potentiated by L-NAME. It is tempting to suggest that 
we have identified an antagonist of PEA at the TAAR. Further studies on the selectivity of 
this antagonism are indicated but the present studies have shown for the first time an action of 
curcumin on vascular responses. Astaxanthin showed a small significant potentiation of the 
PEA contraction but was still not as effective as L-NAME. Astaxanthin fed to hypertensive 
rats lowered blood pressure (Hussein et al., 2005), which was attributed to normalization of 
sympathetic sensitivity, although our results would suggest an opposing vasoconstriction 
through NO scavenging. It is possible that a further increase in our concentration of 
astazanthin may have yielded greater potentiation, but clearly this method is not as effective 
as NOS inhibition. It also suffers from possible non-selective effects arising from scavenging 
other radicals and inhibitory actions at several other sites. It is therefore not recommended for 
studying NO scavenging activity. 
5. Conclusions 
The trace amine, β-phenylethylamine (PEA), and amphetamine exerted vasoconstriction in 
guinea-pig aorta which was not inhibited by prazosin. PEA and amphetamine do not therefore 
exert vasoconstriction of guinea-pig aorta through α1-adrenoceptors but most likely through 
trace amine-associated receptors (TAARs). The responses to PEA and amphetamine were 
potentiated by L-NAME indicating an opposing NO-mediated vasodilatation also not via α1-
adrenoceptors. Nitric oxide scavengers were not an effective means of demonstrating the role 
of NO in these vascular responses. The underlying vasodilatation by these trace amines is 
consistent with dominant vasodilatation in other vascular beds such as the rat isolated 
mesentery (Anwar et al., 2012). The relative importance of vasoconstriction and 
vasodilatation to trace amines clearly depends upon the location and type of blood vessel. 
Since the vasodilator response is NO-mediated, any disruption of the NO pathways would 
have implications in the overall responses to trace amines. For example, in inflammatory 
conditions generating excessive reactive oxygen species, NO could be removed to form 
peroxynitrite and expose enhanced vasoconstriction. 
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Figure Legends 
Fig. 1. Contractions of guinea-pig aorta to β-phenylethylamine (PEA). A. Typical 
cumulative concentration-response curve for PEA with KCl (60 mM) added at the maximum 
dose. B. Control experiments with PEA concentration-response curves added before () and 
repeated in the presence of DMSO (1 in 10) ()(n=4). C. Concentration-response curves for 
PEA before () and in the presence of prazosin (1 µM, ) (n=4). Responses are plotted as 
the increase in tension expressed as a percentage of the maximum contraction to KCl (60 
mM). * Significant difference between with and without DMSO, P<0.05. CRCs were 
significantly different before and after DMSO (1:10) by two-way ANOVA. 
Fig. 2. Effect of prazosin (1 µM) on the contractions of guinea-pig aorta to phenylephrine. 
A. Control experiments with phenylephrine concentration-response curves added before () 
and repeated in the presence of DMSO (1 in 10) () (n=4). B. Concentration-response curves 
for phenylephrine before () and in the presence of prazosin (1 µM, ) (n=4). Responses are 
plotted as the increase in tension expressed as a percentage of the maximum contraction of 
the first concentration-response curve.  * Significant difference between with and without 
prazosin P<0.05. CRCs were significantly different before and after DMSO (1:10) and before 
and after prazosin by two-way ANOVA. 
Fig. 3. Effect of prazosin (1 µM) on the contractions of guinea-pig aorta to d-amphetamine. 
A. Control experiments with d-amphetamine concentration-response curves added before () 
and repeated in the presence of DMSO (1 in 10) () (n=4). B. Concentration-response curves 
for d-amphetamine before () and in the presence of prazosin (1 µM, ) (n=4). Responses 
are plotted as the increase in tension expressed as a percentage of the maximum contraction 
to KCl (60 mM).  * Significant difference between with and without prazosin P<0.05. CRCs 
before and after prazosin were significantly different by two-way ANOVA. 
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Fig. 4. Effect of L-NAME (100 µM) on the contractions of guinea-pig aorta to β-
phenylethylamine (PEA). A. Control experiments with PEA concentration-response curves 
added before () and repeated in the presence of vehicle (distilled water, ) (n=6). B. 
Concentration-response curves for PEA before () and in the presence of L-NAME () 
(n=6). C. Concentration-response curves for PEA before () and in the presence of L-NAME 
() (n=6), both curves in the presence of prazosin (1 µM). Responses are plotted as the 
increase in tension expressed as a percentage of the maximum contraction to KCl (60 mM).  
* Significant difference between with and without L-NAME P<0.05. CRCs before and after 
distilled water not significantly different but CRCs before and after L-NAME with and 
without prazosin were significantly different by two-way ANOVA. 
Fig. 5. Effect of L-NAME (100 µM) on the contractions of guinea-pig aorta to d-
amphetamine. A. Control experiments with PEA concentration-response curves added before 
() and repeated in the presence of vehicle (distilled water, ) (n=4). B. Concentration-
response curves for d-amphetamine before () and in the presence of L-NAME () (n=4). 
Responses are plotted as the increase in tension expressed as a percentage of the maximum 
contraction to KCl (60 mM).  * Significant difference between with and without L-NAME 
P<0.05. CRCs before and after distilled water and before and after L-NAME were 
significantly different by two-way ANOVA. 
Fig. 6. Effect of L-NAME (100 µM) on the contractions of guinea-pig aorta to 
phenylephrine. A. Control experiments with phenylephrine concentration-response curves 
added before (1st curve, ) and repeated in the presence of vehicle (distilled water, 2nd curve ) (n=6). B. Concentration-response curves for phenylephrine before () and in the 
presence of L-NAME () (n=5). Responses are plotted as the increase in tension expressed 
as a percentage of the maximum contraction to KCl (60 mM).  * Significant difference 
between 1st and 2nd curve or between with and without L-NAME P<0.05. CRCs before and 
after distilled water were not significantly different but CRCs before and after L-NAME were 
significantly different by two-way ANOVA. 
Fig. 7. Effects of curcumin (100 µM) and astaxanthin (100 µM) on the contractions of 
guinea-pig aorta to phenylephrine or β-phenylethylamine (PEA). A. Concentration-response 
curves for phenylephrine before () and in the presence of curcumin () (n=5). B. 
Concentration-response curves for PEA before () and in the presence of curcumin () 
(n=6). C. Control experiments with PEA concentration-response curves added before () and 
repeated in the presence of neat DMSO () (n=5). D. Concentration-response curves for 
PEA before () and in the presence of astaxanthin () (n=5). Responses are plotted as the 
increase in tension expressed as a percentage of the maximum contraction to KCl (60 mM).  
* Significant difference between with and without curcumin or astaxanthin P<0.05. CRCs for 
PEA before and after curcumin were significantly different but CRCs for phenylephrine 
before and after curcumin, for PEA before and after DMSO and for PEA before and after 
astaxanthin were not significantly different by two-way ANOVA. 
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